Määräaika päättynyt EU-hankintaKorjattu 23.2.2025

Tertiary data analysis software for reporting germline and/or somatic genetic variants and biomarkers

HUS Group · koko Suomi

Perustiedot

Tarjousten määräaika
ma 10.3.2025 klo 12.00 (päättynyt)
Kysymysten määräaika
pe 14.2.2025 klo 12.00 (päättynyt)
Hankkija
HUS Group, Y-tunnus 1567535-0
Toteutuspaikka
koko Suomi
Hankintalaji
Tavarahankinta
Menettely
Avoin menettely, EU-hankinta
Ilmoituksen tyyppi
Hankintailmoitus
Arvioitu kokonaisarvo
Ei ilmoitettu
Erät
2 erää
Pääasiallinen CPV
48000000 Ohjelmatuotteet ja tietojärjestelmät
Sopimuskausi
24 kuukautta
Julkaistu
23.2.2025
Muutosilmoitus: Julkaisijan virheen korjaaminen

Ilmoituksen teksti

Alkuperäinen teksti Hilmasta, muuttamattomana
The HUS Group requests tenders for Tertiary data analysis software for reporting germline and/or somatic genetic variants and biomarkers. The products are described in more detail in Appendix 4 to the call for tenders (Description of the Procurement). The estimated sample amounts per year on the Appendix 2 (Prices) and the Description of the Implementation Project (Appendix 6) also provide information on the scope of the procurement. Laboratory of Genetics at HUS Diagnostic Center is an SFS-EN ISO 15189:2013 accredited laboratory providing diagnostic genetic testing services mainly to patients at the city of Helsinki and the rest of Uusimaa province. The laboratory employs more than 100 professionals including 21 clinical laboratory geneticists and clinical geneticists. The services include analysis of both constitutional samples and malignancies. The laboratory uses mainly local sequencing capacity (e.g. Illumina NovaSeq 6000 and Ion Torrent S5 equipment) for its services. The laboratory also provides array CGH-based diagnostics using ISCA v2 array (Agilent Technologies) and RNA-based diagnostics using targeted and untargeted sequencing methods. HUS Laboratory of Genetics is seeking a data analysis software service for analyzing, interpreting the clinical significance, and reporting germline and somatic genetic alterations covering whole genome, whole exome and/or genes with the most common clinically relevant alterations (e.g. gene panels). This tender is intended for solutions covering germline (sub-section A) and/or somatic (sub-section B) diseases. Provider’s data analysis software does not have to be capable of both analysis types to respond to this tender. The procurement is divided into lots, as follows: - A. germline analysis - B. somatic analysis. The tenderers may leave a tender to one or more lots as they decide. The goal of this competitive procurement is to simplify the analysis software repertoire and make analysis of multiple data types possible with as few software as possible. This tender is not intended for interpretation services, but the laboratory will carry out sequencing, data analysis and interpretation in-house. RELATED CONTRACT PERIOD AND POSSIBLE OPTIONS See Agreement of the call for tenders for details. The agreement shall be valid for a fixed term of two (2) years, after which it shall continue for an indefinite period. The subject matter and requirements of the procurement are described in detail in the invitation to tender and its appendices.

Muutoksen syy

The procurement unit has updated the Call for Tenders Appendices 3 Software Requirements A. Germline and B. Somatic. The changes have been marked in red. The procurement unit has also extended the tendering period.

Erien kuvaukset

Erä 1: A. Germline analysis
The software must be able to support analysis of SNVs, indels, copy number variations (CNVs), structural variations (SVs) and regions of loss of heterozygosity (LOH). Specifically for somatic analysis, requirements also include reporting of gene fusions, microsatellite instability (MSI), homologous recombination deficiency (HRD), and tumor mutation burden (TMB). Tests are based on analysis of nucleic acids (DNA and/or RNA) extracted from patient tissue or blood samples using next generation sequencing (NGS) on either Ion Torrent or Illumina sequencers as well as array CGH based data (ISCA v2 array, Agilent Technologies), where applicable.

Lisätiedot

The Software Mandatory and Additional Requirements are to be found in Appendix 3. The tenderer must fill in the Prices (Appendix 2) for the germline sub-section (A).
Erä 2: B. Somatic analysis
The software must be able to support analysis of SNVs, indels, copy number variations (CNVs), structural variations (SVs) and regions of loss of heterozygosity (LOH). Specifically for somatic analysis, requirements also include reporting of gene fusions, microsatellite instability (MSI), homologous recombination deficiency (HRD), and tumor mutation burden (TMB). Tests are based on analysis of nucleic acids (DNA and/or RNA) extracted from patient tissue or blood samples using next generation sequencing (NGS) on either Ion Torrent or Illumina sequencers as well as array CGH based data (ISCA v2 array, Agilent Technologies), where applicable.

Lisätiedot

The Software Mandatory and Additional Requirements are to be found in Appendix 3. The tenderer must fill in the Prices (Appendix 2) for the somatic sub-section (B).

Erät

Erä Nimi Ammattiala Arvioitu arvo CPV
1 A. Germline analysis – – 33100000
2 B. Somatic analysis – – 33100000

Hankinnan vaiheet

  1. –Hankintailmoitus

    Aiempi versio. Sen tiedot eivät ole Urakkahaussa.

  2. Muutosilmoitustämä ilmoitus

    Julkaisijan virheen korjaaminen.

  3. TulevaJälki-ilmoitus

    Ei vielä julkaistu.

Lähde: Hilma (hankintailmoitukset.fi)

Ilmoitus 2025-020857

Ilmoita virheestä tai pyydä poistoa